RETRACTED: Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

2000, An overview of regular dialysis treatment in Japan (as of Dec 31, 2000)

Anderson, 1986, Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat, J Clin Invest, 77, 1993, 10.1172/JCI112528

1997, Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy, Lancet, 349, 1857, 10.1016/S0140-6736(96)11445-8

Ruggenenti, 1998, Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial, Lancet, 352, 1252, 10.1016/S0140-6736(98)04433-X

Ruggenenti, 1999, Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria, Lancet, 354, 359, 10.1016/S0140-6736(98)10363-X

Maschio, 1996, Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency: the Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency study group, N Engl J Med, 334, 939, 10.1056/NEJM199604113341502

Locatelli, 1997, Long-term progression of chronic renal insufficiency in the AIPRI Extension Study, Kidney Int, 52, S63

Giatras, 1997, Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials: Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease study group, Ann Intern Med, 127, 337, 10.7326/0003-4819-127-5-199709010-00001

Jafar, 2001, Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease: a meta-analysis of patient-level data, Ann Intern Med, 135, 73, 10.7326/0003-4819-135-2-200107170-00007

Kshirsagar, 2000, Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease: a systematic overview of randomized placebo-controlled trials, Am J Kidney Dis, 35, 695, 10.1016/S0272-6386(00)70018-7

Ruggenenti, 2001, Progression, remission, regression of chronic renal diseases, Lancet, 357, 1601, 10.1016/S0140-6736(00)04728-0

Shiigai, 2001, Late escape from the antiproteinuric effect of ace inhibitors in nondiabetic renal disease, Am J Kidney Dis, 37, 477, 10.1053/ajkd.2001.22069

Toto, 1998, Efficacy and tolerability of losartan in hypertensive patients with renal impairment, Hypertension, 31, 684, 10.1161/01.HYP.31.2.684

Hemmelder, 1999, Antiproteinuric efficacy of verapamil in comparison to trandolapril in non-diabetic renal disease, Nephrol Dial Transplant, 14, 98, 10.1093/ndt/14.1.98

Levey, 1999, A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation, Ann Intern Med, 130, 461, 10.7326/0003-4819-130-6-199903160-00002

Gardman, 1995, A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension, Hypertension, 25, 1345, 10.1161/01.HYP.25.6.1345

Gehan, 1975, Statistical methods for survival time studies, 7

Maschio, 1999, Angiotensin-converting enzyme inhibitors and kidney protection: the AIPRI trial, J Cardiovasc Pharmacol, 33, S16, 10.1097/00005344-199900001-00004

Zucchelli, 1992, Long-term comparison between captopril and nifedipine in the progression of renal insufficiency, Kidney Int, 42, 452, 10.1038/ki.1992.309

Locatelli, 1996, Proteinuria and blood pressure as causal components of progression to end-stage renal failure, Nephrol Dial Transplant, 11, 461, 10.1093/ndt/11.3.461

Lewis, 1993, The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy, N Engl J Med, 329, 1456, 10.1056/NEJM199311113292004

Russo, 1999, Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy, Am J Kidney Dis, 33, 851, 10.1016/S0272-6386(99)70416-6

Mogensen, 2000, Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study, BMJ, 321, 1440, 10.1136/bmj.321.7274.1440

Ruilope, 2000, Safety of the combination of valsartan and benazepril in patients with chronic renal disease, JHypertens, 18, 89, 10.1097/00004872-200018010-00013

Herbert, 1999, Combination ACE inhibitor and angiotensin II receptor antagonist therapy in diabetic nephropathy, Am J Nephrol, 19, 1, 10.1159/000013417

Agarwal, 2001, Add-on angiotensin receptor blockade with maximized ACE inhibition, Kidney Int, 59, 2282, 10.1046/j.1523-1755.2001.00745.x

Coles, 2000, Clinical interventions in chronic renal failure, 401